Elanco Animal Health Incorporated Proceeds from Divestiture of Businesses
Elanco Animal Health Incorporated (ELAN) reported Proceeds from Divestiture of Businesses of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2026-08-05
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for the quarter ending 2026-06-30 was $0.00.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for the quarter ending 2025-12-31 was $0.00.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for fiscal 2025 was $9.00M, a 99.34% decline from fiscal 2024.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for fiscal 2024 was $1.36B.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for fiscal 2023 was $0.00.
- Elanco Animal Health Incorporated proceeds from divestiture of businesses for fiscal 2022 was $0.00.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 9 month as first filed | Proceeds from Divestiture of Businesses 12 month | Proceeds from Divestiture of Businesses 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $9.00M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $9.00M 10-Q · filed 2025-11-05 | $9.00M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.00M 10-Q · filed 2026-08-05 | $9.00M derived: sum of 3 quarters · filed 2026-08-05 | $1.30B derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $9.00M 10-Q · filed 2026-05-06 | $9.00M derived: sum of 2 quarters · filed 2026-05-06 | $1.30B derived: sum of 3 quarters · filed 2026-05-06 | $1.30B derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.29B derived: sum of 2 quarters · filed 2026-02-24 | $1.29B derived: sum of 3 quarters · filed 2026-02-24 | $1.36B 10-K · filed 2026-02-24 | $1.29B 10-K · filed 2025-02-25 | |
| 2024-09-30 | $1.29B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.29B derived: sum of 2 quarters · filed 2025-11-05 | $1.36B 10-Q · filed 2025-11-05 | $1.29B 10-Q · filed 2024-11-07 | $1.36B derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $66.00M 10-Q · filed 2025-08-07 | $66.00M derived: sum of 3 quarters · filed 2026-02-24 | |||
| 2024-03-31 | $66.00M 10-Q · filed 2025-05-07 | $66.00M derived: sum of 2 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |